Home > Category > Signaling Pathways > Cell Cycle > Aurora Kinase > CYC-116 (Synonyms: CYC116; 5-[2,5-Dihydro-2-[[4-(4-morpholinyl)phenyl]imino]-4-pyrimidinyl]-4-methyl-2-thiazolamine)

CYC-116 (Synonyms: CYC116; 5-[2,5-Dihydro-2-[[4-(4-morpholinyl)phenyl]imino]-4-pyrimidinyl]-4-methyl-2-thiazolamine)

ChemLeader 98+%

Catalog No：CL2338 CAS No.：1059105-22-4 MDLNo： Formula：C₁₈H₂₀N₆OS MW：368.46

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
10 mg	In-stock	$118.00	Visible after login	- +
50 mg	In-stock	$218.00	Visible after login	- +
100 mg	In-stock	$366.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Certificate Of Authenticity(CPA)

Download COA

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	CYC-116 (Synonyms: CYC116; 5-[2,5-Dihydro-2-[[4-(4-morpholinyl)phenyl]imino]-4-pyrimidinyl]-4-methyl-2-thiazolamine)
CAS	1059105-22-4
Formula	C₁₈H₂₀N₆OS
MW	368.46
Appearance	Yellowish to yellow powder
Storage condition	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Product details

CYC-116 is an Aurora kinase inhibitor used to treat patients with advanced solid tumors.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CL2338

CYC-116 (Synonyms: CYC116; 5-[2,5-Dihydro-2-[[4-(4-morpholinyl)phenyl]imino]-4-pyrimidinyl]-4-methyl-2-thiazolamine)